84228-44-4Relevant articles and documents
HALOALLYLAMINE PYRAZOLE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF
-
Paragraph 0337, (2018/09/20)
The present invention relates to novel compounds which are capable of inhibiting certain amine oxidase enzymes. These compounds are useful for treatment of a variety of indications, e.g., fibrosis, cancer and/or angiogenesis in human subjects as well as i
SELECTIVE CYSTEINE PROTEASE INHIBITORS AND USES THEREOF
-
Paragraph 0262; 0263, (2018/03/25)
The present invention relates to compounds of Formula I, II, IA-VA, IVA1-IVA5, IIIA1-IIIA5 and their pharmaceutical uses. Particular aspects of the invention relate to the use of those compounds for the selective inhibition of one or more cysteine proteas
2-Trifluoromethyl-2-Hydroxypropionamide Derivatives as Novel Reversal Agents of ABCG2 (BCRP)-Mediated Multidrug Resistance: Synthesis and Biological Evaluations
Kathawala, Rishil J.,Li, Tianwen,Yang, Danwen,Guo, Hui-Qin,Yang, Dong-Hua,Chen, Xiang,Cheng, Changmei,Chen, Zhe-Sheng
, p. 2420 - 2429 (2017/06/13)
It has been postulated that one of the biggest impediments to a successful chemotherapy is the phenomena of multidrug resistance (MDR) in cancer cells. One of the main mechanisms of MDR is overexpression of the ATP-binding cassette (ABC) transporters in c